Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Haloperidol

From PsychonautWiki Archive
Revision as of 14:12, 28 January 2017 by >Kenan (Reverted edits by Kaylee (talk) to last revision by Sir Kibs)
Jump to navigation Jump to search

This article is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

Template:Proofread
Haloperidol
Chemical Nomenclature
Common names Haldol
Substitutive name Haloperidol
Systematic name 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
Class Membership
Psychoactive class Antipsychotic
Chemical class Butyrophenone / Phenylpiperidine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Bioavailability 60-70%
Threshold 0.25 mg
Light 0.25 - 1 mg
Common 1 - 5 mg
Strong 5 - 10 mg
Heavy 10 mg +
Duration
Total 12 - 36 hours
Onset 30 - 60 minutes









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions
Summary sheet: Haloperidol

Haloperidol (trade name Haldol) is an antipsychotic drug used to treat a variety of mental disorders, such as schizophrenia, mania, bipolar disorder, delirium, psychosis, Tourette syndrome, as well as other symptoms. It was first synthesized in 1958 by Paul Janssen[1] from meperidine[2]. Haloperidol is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.[3] It is also one of the most frequently prescribed typical antipsychotics and is sometimes carried by medical services as an emergency sedative.

Chemistry

This chemistry section is incomplete.

You can help by adding to it.

Haloperidol is a molecule of the butyrophenone class.

Pharmacology

This pharmacology section is incomplete.

You can help by adding to it.

As a typical antipsychotic, haloperidol has a diverse pharmacological profile. Primarily, haloperidol acts on dopamine D2 receptors as an antagonist, as well as a D3 inverse agonist. Haloperidol is also an antagonist of the 5-HT2A receptor, although this effect is not as powerful as that of quetiapine. Unlike many antipsychotcs, haloperidol has negligible affinity for the muscarinic acetylcholine receptors as well as the histamine receptors, which results in less sedation, weight gain and hypotension.[4]

Subjective effects

This subjective effects section is a stub.

As such, it is still in progress and may contain incomplete or wrong information.

You can help by expanding or correcting it.

Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.

It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.

Physical effects

Cognitive effects

Toxicity and harm potential

This toxicity and harm potential section is a stub.

As a result, it may contain incomplete or even dangerously wrong information! You can help by expanding upon or correcting it.
Note: Always conduct independent research and use harm reduction practices if using this substance.

Haloperidol can have serious side effects at higher dosages, such as risk of having severe extrapyramidal symptoms and muscle rigidity, which can last for hours.

Both typical and atypical antipsychotics can cause tardive dyskinesia.[5] According to one study, rates are lower with the atypicals at 3.9% as opposed to the typicals at 5.5%.[6] Switching to these atypicals is an option to minimize symptoms of tardive dyskinesia caused by other atypicals.[7]

It is strongly recommended that one use harm reduction practices when using this drug.

  • Australia: The drug is available via prescription only.
  • Canada: The drug is available via prescription only.
  • United States: The drug is available via prescription only.
  • United Kingdom: Haloperidol is a prescription-only medication.

See also

References